EASY BIO,Inc.
KOSDAQTotal Valuation
EASY BIO,Inc. carries a market capitalization of 200.81B, placing it among publicly traded companies globally. Its enterprise value stands at 351.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 200.81B |
| Enterprise Value | 351.80B |
Share Statistics
EASY BIO,Inc. currently has 33.08M shares outstanding.
| Shares Outstanding | 33.08M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
EASY BIO,Inc. trades at a trailing price-to-earnings ratio of 6.86. The price-to-sales ratio is 0.47, and the price-to-book ratio stands at 2.70.
| PE Ratio | 6.86 |
| PS Ratio | 0.47 |
| PB Ratio | 2.70 |
| P/TBV Ratio | 5.99 |
| P/FCF Ratio | 5.33 |
| P/OCF Ratio | 6.54 |
Enterprise Valuation
On an enterprise value basis, EASY BIO,Inc. trades at an EV/EBITDA multiple of 7.16 and an EV/FCF ratio of 7.32. The EV/Sales ratio of 0.72 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.16 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.72 |
| EV / EBITDA | 7.16 |
| EV / EBIT | 7.16 |
| EV / FCF | 7.32 |
Financial Position
EASY BIO,Inc. maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 136.06, indicating elevated leverage, while an interest coverage ratio of 7.39 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.23 |
| Quick Ratio | 0.30 |
| Debt / Equity | 136.06 |
| Debt / EBITDA | 3.33 |
| Interest Coverage | 7.39 |
Financial Efficiency
EASY BIO,Inc. posts a return on equity of 46.24 and a return on invested capital of 14.03.
| Return on Equity (ROE) | 46.24 |
| Return on Assets (ROA) | 9.92 |
| Return on Invested Capital (ROIC) | 14.03 |
| Return on Capital Employed (ROCE) | 15.47 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.62 |
Taxes
Over the trailing twelve months, EASY BIO,Inc. has paid 11.19B in income taxes, reflecting an effective tax rate of 24.14.
| Income Tax | 11.19B |
| Effective Tax Rate | 24.14 |
Stock Price Statistics
EASY BIO,Inc.'s stock has gained approximately 13.45794% over the past 52 weeks. The 50-day moving average sits at 6,792.40, while the 200-day moving average is 6,637.15.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.45794% |
| 50-Day Moving Average | 6,792.40 |
| 200-Day Moving Average | 6,637.15 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, EASY BIO,Inc. generated 490.70B in revenue and converted that into 33.41B in net income, yielding earnings per share of 1,062.99. EBITDA reached 49.10B, while operating income came in at 49.10B.
| Revenue | 490.70B |
| Gross Profit | 129.18B |
| Operating Income | 49.10B |
| Pretax Income | 46.36B |
| Net Income | 33.41B |
| EBITDA | 49.10B |
| EBIT | 49.10B |
| Earnings Per Share (EPS) | 1,062.99 |
Balance Sheet
EASY BIO,Inc. holds 46.96B in cash and equivalents against 163.68B in total debt, resulting in a net debt position of 117.53B. Total book value stands at 85.00B, with working capital of 36.32B providing operational flexibility.
| Cash & Cash Equivalents | 46.96B |
| Total Debt | 163.68B |
| Net Debt | 117.53B |
| Equity (Book Value) | 85.00B |
| Book Value Per Share | 2,569.05 |
| Working Capital | 36.32B |
Cash Flow
EASY BIO,Inc. produced 35.05B in operating cash flow over the past twelve months. After subtracting -7.99B in capital expenditures, free cash flow totaled 27.06B - equivalent to 817.80 per share.
| Operating Cash Flow | 35.05B |
| Capital Expenditures | -7.99B |
| Free Cash Flow | 27.06B |
| FCF Per Share | 817.80 |
Margins
EASY BIO,Inc. operates with a gross margin of 26.33, reflecting its pricing power and cost economics. The operating margin of 10.01 and net profit margin of 6.81 provide insight into operational efficiency.
| Gross Margin | 26.33 |
| Operating Margin | 10.01 |
| Pretax Margin | 9.45 |
| Profit Margin | 6.81 |
| EBITDA Margin | 10.01 |
Dividends & Yields
The company's payout ratio of 0.74 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 8.23 |
| Dividend Yield | N/A |
| Payout Ratio | 0.74 |
| Shareholder Yield | 3.79 |
| FCF Yield | 18.77 |
Stock Splits
EASY BIO,Inc.'s most recent stock split took place on December 21, 2020 with a 1:5 split ratio.
| Last Split Date | 12/21/2020 |
| Split Ratio | 1:5 |
Scores
EASY BIO,Inc. posts an Altman Z-Score of 3.47, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.47 |